Expanding the Clinical and Genetic Spectrum of TTLL5-Associated Retinal Dystrophy: A Single-Center Cohort Study [0.03%]
TTLL5相关性视网膜 dystrophy的临床和遗传特点扩展的一项单中心队列研究
Yunyu Zhou,Yue Liu,Huan Chen et al.
Yunyu Zhou et al.
Purpose: To characterize the clinical and genetic spectrum of TTLL5-related retinal dystrophy. Design: Retrospective observational stud...
Lysinibacillus fusiformis Endophthalmitis after Intravitreal Anti-VEGF for Retinopathy of Prematurity [0.03%]
用于治疗早产儿视网膜病变的抗VEGF药物玻璃体内注射后继发lysiniabaciilus fusiformis眼内炎
Parijat Chandra,Vineet Batwani,Karnika Saigal
Parijat Chandra
Yitong Li,Nan Zhou,Wen-Bin Wei
Yitong Li
RE: Bondok et al.: Sociodemographic Reporting in Artificial Intelligence Studies of Retinal Diseases: A Critical Appraisal of The Literature (Ophthalmology Retina. 2025; 12: 1133-1139) [0.03%]
关于邦多克等人的评论：视网膜疾病人工智能研究的社会人口学报告：对文献的批判性评价（Ophthalmology Retina. 2025; 12: 1133-1139）
Henry Bair,Sidra Zafar
Henry Bair
Impact of Baseline BCVA on Outcomes with Aflibercept 8 mg in Patients with DME [0.03%]
基线BCVA对DME患者使用阿柏西普8mg疗效的影响
Michael Javaheri,Priya S Vakharia,Talia R Kaden et al.
Michael Javaheri et al.
Aflibercept 8 mg demonstrated comparable visual and anatomic improvements versus 2 mg in patients with diabetic macular edema at week 96, regardless of baseline best-corrected visual acuity ≤20/50 versus ≥20/40. ...
Maculopathy in Paclitaxel Users: Nationwide Drug Use, Incidence, and Risk Factors [0.03%]
紫杉醇使用者的黄斑病变化：全国范围内的药物使用、发病率和风险因素分析
Sunjin Hwang,Jiyeong Kim,Jee-Eun Chung et al.
Sunjin Hwang et al.
Purpose: To determine the real-world incidence and risk factors for maculopathy among new paclitaxel users in South Korea. Design: Retr...
Cataract Progression and Risk Factors for Cataract Surgery after Pars Plana Vitrectomy in Phakic Eyes - an IRIS® Registry Analysis [0.03%]
玻璃体切割术后的白内障进展及复明注册研究(IRIS)registry)数据库分析
Jay C Wang,Rahul N Khurana,Lynn Liu et al.
Jay C Wang et al.
Purpose: To investigate the probability of cataract surgery after pars plana vitrectomy (PPV) in phakic eyes using the IRIS® Registry (Intelligent Research in Sight), and to identify risk factors for subsequent cataract ...
Proliferative Vitreoretinopathy Exhibiting Metaplastic Pseudovascular Morphology [0.03%]
增生性玻璃体视网膜病变伴血管样肉芽组织增值体质形态
Eric J Kim,Elizabeth J Rossin,Anna M Stagner
Eric J Kim
Timing and Determinants of Post-Injection Endophthalmitis After First-Time Anti-VEGF Administration: A Retrospective National Study in the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) [0.03%]
美国眼科学会IRIS数据库首次抗血管内皮生长因子注射后终板玻璃体视网膜炎的发病时间及危险因素：回顾性全国研究
Sophia Y Ghauri,Connor Ross,Joshua B Gilbert et al.
Sophia Y Ghauri et al.
Purpose: To investigate the epidemiology of post-injection endophthalmitis (PIE) after first anti-VEGF administration and evaluate the association of sociodemographic and clinical factors with incidence, timing of onset, ...
Mousumi Banerjee,Nikita Vilasrao Bhosale,Thirumalesh Mochi Basavaraj
Mousumi Banerjee